Lv1
58 积分 2025-03-18 加入
Targeted degradation of BRD4 by PROTACs: advances in cancer therapy
19小时前
待确认
Discovery of novel potent PI3K/mTOR dual‐target inhibitors based on scaffold hopping: Design, synthesis, and antiproliferative activity
6天前
已完结
Based on virtual screening methods and biological activity assessment, AK-968/13030056 has been identified as a potential mTOR inhibitor
6天前
已完结
Pyrrole‐based EGFR inhibitors for the treatment of NCSLC: Binding modes and SARs investigations
6天前
已完结
An updated patent review of small-molecule c-Met kinase inhibitors (2018-present)
6天前
已完结
Design, synthesis and biological evaluation of 4-phenoxy-pyridine/pyrimidine derivatives as dual VEGFR-2/c-Met inhibitors
6天前
已完结
Design, synthesis, and evaluation of antitumor activity of Mobocertinib derivatives, a third-generation EGFR inhibitor
6天前
已完结
A review of artificial intelligence (AI)-based applications to nanocomposites
9天前
已完结
Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response
9天前
已完结
Development of PROTACs using computational approaches
21天前
已完结
皖公网安备34019202002308
